ARCHIVES

Most Comprehensive Centers Getting Core Grants Renewed

This article is from The Cancer Letter archive.

Vol. 16 No. 30 | July 27, 1990

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Trials Listed

March 30, 2007

ACS Says 41 Percent Survive 5 Years

January 2, 1981

Chabner Calls For Audit Of I-ELCAP Data, Full Financial Disclosure.

May 2, 2008

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009

In Brief: NCI Award 14 Contracts to Operate The Cancer Information Service

August 13, 1999

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

July 6, 1990